Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 25 articles:
HTML format

Single Articles


    July 2008
  1. LIU Z , Marquez M, Nilsson S, Holmberg AR, et al
    Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
    Oncol Rep. 2008;20:151-4.
    PubMed     Related articles    Abstract available


    May 2008
  2. WAGENER M , Zhang X, Villarreal HG, Levy L, et al
    Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancer.
    Oncol Rep. 2008;19:1071-7.
    PubMed     Related articles    Abstract available


    April 2008
  3. BRONZETTI E , Artico M, Forte F, Pagliarella G, et al
    A possible role of BDNF in prostate cancer detection.
    Oncol Rep. 2008;19:969-974.
    PubMed     Related articles    Abstract available


    March 2008
  4. SHABBIR M , Love J, Montgomery B
    Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer.
    Oncol Rep. 2008;19:831-5.
    PubMed     Related articles    Abstract available


    February 2008
  5. DACHILLE G , Cai T, Ludovico GM, Vestita G, et al
    Prognostic role of cell apoptotic rate in prostate cancer: Outcome of a long-time follow-up study.
    Oncol Rep. 2008;19:541-5.
    PubMed     Related articles    Abstract available


    January 2008
  6. MAO K , Camparo P, Badoual C, Peyromaure M, et al
    The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy.
    Oncol Rep. 2008;19:171-5.
    PubMed     Related articles    Abstract available


  7. VARE P , Loikkanen I, Hirvikoski P, Vaarala MH, et al
    Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma.
    Oncol Rep. 2008;19:25-31.
    PubMed     Related articles    Abstract available


    November 2007
  8. FESTUCCIA C , Gravina GL, Muzi P, Biordi L, et al
    Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients.
    Oncol Rep. 2007;18:1321-7.
    PubMed     Related articles    Abstract available


  9. LENNERNAS B , Albertsson P, Edgren M, Nilsson S, et al
    Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
    Oncol Rep. 2007;18:1299-303.
    PubMed     Related articles    Abstract available


  10. ITOH Y , Komohara Y, Komatsu N, Minami T, et al
    New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patients.
    Oncol Rep. 2007;18:1231-7.
    PubMed     Related articles    Abstract available


  11. FUKUDA H , Tsuchiya N, Narita S, Kumazawa T, et al
    Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Oncol Rep. 2007;18:1155-63.
    PubMed     Related articles    Abstract available


  12. YAMASAKI M , Nomura T, Sato F, Mimata H, et al
    Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
    Oncol Rep. 2007;18:1145-53.
    PubMed     Related articles    Abstract available


    August 2007
  13. FESTUCCIA C , Gravina GL, Millimaggi D, Muzi P, et al
    Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells.
    Oncol Rep. 2007;18:503-11.
    PubMed     Related articles    Abstract available


  14. MOMII Y , Izumi H, Shiota M, Onitsuka T, et al
    p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
    Oncol Rep. 2007;18:411-6.
    PubMed     Related articles    Abstract available


  15. HOMMA S , Komohara Y, Harada M, Saya H, et al
    Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: The robustness of prostate cancer.
    Oncol Rep. 2007;18:343-6.
    PubMed     Related articles    Abstract available


    July 2007
  16. PEYROMAURE M , Badoual C, Camparo P, Grabar S, et al
    Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.
    Oncol Rep. 2007;18:145-9.
    PubMed     Related articles    Abstract available


  17. MATSUYAMA M , Hayama T, Funao K, Kawahito Y, et al
    Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
    Oncol Rep. 2007;18:99-104.
    PubMed     Related articles    Abstract available


  18. TANAKA M , Komatsu N, Terakawa N, Yanagimoto Y, et al
    Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients.
    Oncol Rep. 2007;18:161-6.
    PubMed     Related articles    Abstract available


    June 2007
  19. CASH J , Korchnak A, Gorman J, Tandon Y, et al
    VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
    Oncol Rep. 2007;17:1413-9.
    PubMed     Related articles    Abstract available


    May 2007
  20. WINNES M , Lissbrant E, Damber JE, Stenman G, et al
    Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
    Oncol Rep. 2007;17:1033-6.
    PubMed     Related articles    Abstract available


    April 2007
  21. KANZAKI M , Kakinuma H, Kumazawa T, Inoue T, et al
    Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells.
    Oncol Rep. 2007;17:761-7.
    PubMed     Related articles    Abstract available


    December 2006
  22. VAN VELDHUIZEN PJ , Thrasher JB, Ray G, Cherian R, et al
    Dose effect of soy supplementation in prostate cancer: A pilot study.
    Oncol Rep. 2006;16:1221-4.
    PubMed     Related articles    Abstract available


    September 2006
  23. LLEONART ME , Vidal F, Gallardo D, Diaz-Fuertes M, et al
    New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas.
    Oncol Rep. 2006;16:603-8.
    PubMed     Related articles    Abstract available


    July 2006
  24. MERSEBURGER AS , Hennenlotter J, Simon P, Muller CC, et al
    Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
    Oncol Rep. 2006;16:79-83.
    PubMed     Related articles    Abstract available


    June 2006
  25. KUNZE D , Fuessel S, Meye A, Wirth MP, et al
    Functional analyses of C13orf19/P38IP in prostate cell lines.
    Oncol Rep. 2006;15:1599-604.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: